Matches in Wikidata for { <http://www.wikidata.org/entity/Q64140113> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64140113 description "clinical trial" @default.
- Q64140113 description "ensayu clínicu" @default.
- Q64140113 description "klinisch onderzoek" @default.
- Q64140113 description "клінічне випробування" @default.
- Q64140113 name "Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma" @default.
- Q64140113 type Item @default.
- Q64140113 label "Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma" @default.
- Q64140113 prefLabel "Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma" @default.
- Q64140113 P1050 Q64140113-A423048F-327F-41E7-BAE8-79264189ACEC @default.
- Q64140113 P1132 Q64140113-70E169B4-69ED-40B3-AB39-A68F7E3C48B6 @default.
- Q64140113 P1476 Q64140113-845642E7-2699-46F0-800C-D005B0A79EDC @default.
- Q64140113 P17 Q64140113-C355D054-82F2-4C8C-A25E-70B6C12930B7 @default.
- Q64140113 P17 Q64140113-D70FFD55-8E20-4482-BFC7-4206B6D7FC2B @default.
- Q64140113 P2899 Q64140113-ACFBEF42-CC12-4A78-85B0-2981BA71BB2A @default.
- Q64140113 P3098 Q64140113-0456DB9F-E572-49DB-89DD-49B20B779F8C @default.
- Q64140113 P31 Q64140113-AD29D428-95A4-4B10-B37F-022CB7E8EAE1 @default.
- Q64140113 P4844 Q64140113-1E8C49A3-D3F1-4642-8612-86D0108521FA @default.
- Q64140113 P4844 Q64140113-3BD23F86-9EEE-4805-BAFE-45D0EA47E732 @default.
- Q64140113 P4844 Q64140113-FE550B9A-C771-42BD-9874-89EDC75CD083 @default.
- Q64140113 P580 Q64140113-C1C60031-C3FC-4496-872B-EC211BF49F32 @default.
- Q64140113 P582 Q64140113-4914230E-B104-459C-A517-95693647F87F @default.
- Q64140113 P6099 Q64140113-1AA31E0B-E66B-462F-AB82-ED9B58B33FF4 @default.
- Q64140113 P6099 Q64140113-94E42864-79D4-4E8D-88D4-42384AFB7247 @default.
- Q64140113 P6153 Q64140113-03BE3C8D-FE10-4155-A57E-AB2A20AD3B64 @default.
- Q64140113 P6153 Q64140113-2DA1ECD9-1CD6-4C1F-A3B0-9BABDB32D404 @default.
- Q64140113 P6153 Q64140113-333BF909-26AA-4984-9669-4526B822C7A2 @default.
- Q64140113 P6153 Q64140113-46462E9A-2FBF-4B86-A4E3-27D59C79DF3C @default.
- Q64140113 P6153 Q64140113-9E4A7BCA-51E3-42E8-BEF3-6D8BF5F86356 @default.
- Q64140113 P6153 Q64140113-C90FBBD5-48D7-4D34-B96C-312D905359AD @default.
- Q64140113 P6153 Q64140113-DA3F677E-9B03-4780-ABBD-AA9A97C8B8FE @default.
- Q64140113 P6153 Q64140113-FB4C4395-9911-440E-9792-B67629D502DA @default.
- Q64140113 P767 Q64140113-242CE178-5F6A-4233-A92A-301DE7283D4C @default.
- Q64140113 P8363 Q64140113-9716C365-03A3-4E86-A984-40EB2A961A3D @default.
- Q64140113 P1050 Q1077603 @default.
- Q64140113 P1132 "+126" @default.
- Q64140113 P1476 "A Phase II/III Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma" @default.
- Q64140113 P17 Q16 @default.
- Q64140113 P17 Q38 @default.
- Q64140113 P2899 "+18" @default.
- Q64140113 P3098 "NCT02784171" @default.
- Q64140113 P31 Q30612 @default.
- Q64140113 P4844 Q13896859 @default.
- Q64140113 P4844 Q412415 @default.
- Q64140113 P4844 Q415220 @default.
- Q64140113 P580 "2016-10-07T00:00:00Z" @default.
- Q64140113 P582 "2019-05-01T00:00:00Z" @default.
- Q64140113 P6099 Q42824440 @default.
- Q64140113 P6099 Q42824827 @default.
- Q64140113 P6153 Q2945711 @default.
- Q64140113 P6153 Q30279879 @default.
- Q64140113 P6153 Q30282110 @default.
- Q64140113 P6153 Q3145168 @default.
- Q64140113 P6153 Q4835275 @default.
- Q64140113 P6153 Q5188247 @default.
- Q64140113 P6153 Q632891 @default.
- Q64140113 P6153 Q7270360 @default.
- Q64140113 P767 Q76473 @default.
- Q64140113 P8363 Q78089383 @default.